Literature DB >> 7548290

The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro.

T J O'Connor1, D Kinchington, H O Kangro, D J Jeffries.   

Abstract

The effect of low pH, normally present in the female genital tract, on HIV viability was examined. HIV is more acid stable than previously reported with no substantial reduction in infectivity occurring until pH levels are reduced below 4.5. The virucidal activity of 3 topical spermicides and chlorhexidine was assessed in vitro using previously established and newly modified assay systems. None of the agents tested had a selectivity index (SI) greater than 5.2. Semen and cervical secretions were assessed for their ability to inhibit HIV-1. While no virucidal effect was found in the latter, seminal fluid was found to have significant activity against HIV-1 and a SI of approximately 50.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548290     DOI: 10.1177/095646249500600409

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  21 in total

Review 1.  Microbicides: topical prevention against HIV.

Authors:  Robin J Shattock; Zeda Rosenberg
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

2.  Morphology-Dependent HIV-Enhancing Effect of Semen-Derived Enhancer of Viral Infection.

Authors:  Xin Qiao; Jaekyun Jeon; Amy L Cole; Jason O Matos; Stephany Bautista; Justin Castillo; Ivan Hung; Zhehong Gan; Suren A Tatulian; Alexander M Cole; Bo Chen
Journal:  Biophys J       Date:  2015-04-21       Impact factor: 4.033

3.  In vivo semen-associated pH neutralization of cervicovaginal secretions.

Authors:  C Tevi-Bénissan; L Bélec; M Lévy; V Schneider-Fauveau; A Si Mohamed; M C Hallouin; M Matta; G Grésenguet
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

4.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

Review 5.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

6.  Deep sequencing of the vaginal microbiota of women with HIV.

Authors:  Ruben Hummelen; Andrew D Fernandes; Jean M Macklaim; Russell J Dickson; John Changalucha; Gregory B Gloor; Gregor Reid
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

7.  Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method.

Authors:  James E Cummins; Julie M Villanueva; Tammy Evans-Strickfaden; Shekou M Sesay; Sheila R Abner; Timothy J Bush; Timothy A Green; Jeffrey L Lennox; Thomas Wright; Thomas M Folks; Clyde E Hart; Charlene S Dezzutti
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

8.  Human Semen or Seminal Plasma Does Not Enhance HIV-1BaL Ex Vivo Infection of Human Colonic Explants.

Authors:  Kattayoun Kordy; Julie Elliott; Karen Tanner; Elizabeth J Johnson; Ian M McGowan; Peter A Anton
Journal:  AIDS Res Hum Retroviruses       Date:  2018-02-21       Impact factor: 2.205

9.  Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis.

Authors:  Caroline Mitchell; Carla Moreira; David Fredricks; Kathleen Paul; Angela M Caliendo; Jaclynn Kurpewski; Jessica Ingersoll; Susan Cu-Uvin
Journal:  Infect Dis Obstet Gynecol       Date:  2009-11-12

10.  Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein.

Authors:  Daniel J Stieh; Joshua L Phillips; Paul M Rogers; Deborah F King; Gianguido C Cianci; Simon A Jeffs; Sandrasegaram Gnanakaran; Robin J Shattock
Journal:  Retrovirology       Date:  2013-03-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.